The effects of β-glucans on cancer metastasis

Anti-Cancer Agents in Medicinal Chemistry

Volumn 13, Issue 5, 2013, Pages 699-708

  Yoon, Taek Joon ^a   Koppula, Sushruta ^b   Lee, Kwang Ho ^b  

^a Yuhan College   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

glucan; Anti metastatic; Immunomodulatory; Zymosan

Indexed keywords

BETA GLUCAN; DECTIN 1; FLUOROURACIL; GELATINASE A; GELATINASE B; GLYCOSPHINGOLIPID; INTERLEUKIN 1BETA; LACTOSYLCERAMIDE; MITOMYCIN; SCAVENGER RECEPTOR; SCHIZOPHYLLAN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BONE MARROW; CANCER PREVENTION; CD4 CD8 RATIO; CELL PROLIFERATION; CLINICAL TRIAL (TOPIC); CYTOTOXICITY; HUMAN; METASTASIS; MUSHROOM; NONHUMAN; REVIEW; TUMOR GROWTH;

ANIMALS; BETA-GLUCANS; CLINICAL TRIALS AS TOPIC; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 84880144558     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/1871520611313050004     Document Type: Review

References (130)

1. Akramiene, D.; Kondrotas, A.; Didziapetriene, J.; Kevelaitis, E. Effects of beta-glucans on the immune system. Medicina (Kaunas), 2007, 43(8), 597-606.
2. Seviour, R.J.; Stasinopoulos, S.J.; Auer, D.P.D.; Gibbs, P.A. Production of pullulan and other Exopolysaccharides by Filamentous Fungi. Crit. Rev. Biotechnol., 1992, 12, 279-298.
3. Klis, F.M.; de Groot, P.; Hellingwerf, K. Molecular organization of the cell wall of Candida albicans. Med. Mycol., 2001, 39, 1-8.
4. McIntosh, M.; Stone, B.A.; Stanisich, V.A. Curdlan and other bacterial (1/3)-b-D-glucans. Appl. Microbiol. Biotechnol., 2005, 68, 163-173.
5. Brown, G.D.; Gordon, S. Immune recognition of fungal β-glucans. Cell. Microbiol., 2005, 7, 471-479.
6. Vetvicka, V.; Yvin, J.C. Effects of marine b-1,3 glucan on immune reactions. Int. Immunopharmacol., 2004, 4, 721-730.
7. Nakao, I.; Uchino, H.; Orita, K.; Kaido, I.; Kimura, T.; Goto, Y.; Kondo, T.; Takino, T.; Taguchi, T.; Nakajima, T. Clinical evaluation of schizophyllan (SPG) in advanced gastric cancer--a randomized comparative study by an envelope method. Gan. To. Kagaku. Ryoho., 1983, 10, 1146-1159.
8. Inomata, T.; Goodman, G.B.; Fryer, C.J.; Chaplin, D.J.; Palcic, B.; Lam, G.K.; Nishioka, A.; Ogawa, Y. Immune reaction induced by X-rays and pions and its stimulation by schizophyllan (SPG). Br. J. Cancer, 1996, 27, S122-S125.
9. Yoon, T.J.; Kim, T.J.; Lee, H.; Shin, K.S.; Yun, Y.P.; Moon, W.K.; Kim, D.W.; Lee, K.H. Anti-tumor metastatic activity of betaglucan purified from mutated Saccharomyces cerevisiae. Int. Immunopharmacol., 2008, 8, 36-42.
10. Li, H.; Kim, W.J.; Jiang, J.; Lee, S.H.; Youn, H. S,; Moon, E.Y.; Kim, T.J.; Ye, S.K.; Ryu, J.H.; Kang, T.B.; Koppula, S.; Park, P.J.; Choi, D.K.; Lee, K.H. MyD88-dependent Toll-like receptor signaling is required for murine macrophages response to IS2. Int. Immunopharmacol., 2011, 11(10), 1578-1583.
11. Zhong, W.; Hansen, R.; Li, B.; Cai, Y.; Salvador, C.; Moore, G.D.; Yan, J. Effect of yeast-derived beta-glucan in conjunction with bevacizumab for the treatment of human lung adenocarcinoma in subcutaneous and orthotopic xenograft models. J. Immunother., 2009, 32(7), 703-712.
12. Kodama, N.; Komuta, K.; Nanba, H. Can maitake MD-fraction aid cancer patients? Altern. Med. Rev., 2002, 7, 236-239.
13. Kodama, N.; Murata, Y.; Asakawa, A.; Inui, A.; Hayashi, M.; Sakai, N.; Nanba, H. Maitake D-Fraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumorbearing mice. Nutrition., 2005, 21, 624-629.
14. Kodama, N.; Asakawa, A.; Inui, A.; Masuda, Y. Nanba H. Enhancement of cytotoxicity of NK cells by D-Fraction, a polysaccharide from Grifola frondosa. Oncol. Rep., 2005, 13, 497-502
15. Mayell, M. Maitake extracts and their therapeutic potential. Altern. Med. Rev., 2001, 6, 48-60.
16. Kodama, N.; Komuta, K.; Nanba, H. Effect of Maitake (Grifola frondosa) D-Fraction on the activation of NK cells in cancer patients. J. Med. Food., 2003, 6, 371-377.
17. Chihara, G.; Hamuro, J.; Maeda, Y.; Arai, Y.; Fukuoka, F. Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes (Berk.) Sing. (an edible mushroom). Cancer Res., 1970, 30, 2776-2781.
18. Ladányi, A.; Tímár, J.; Lapis, K. Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells. Cancer Immunol. Immunother., 1993, 36, 123-126.
19. Takita, M.; Onda, M.; Tokunaga, A.; Shirakawa, T.; Ikeda, K.; Hiramoto, Y.; Teramoto, T.; Oguri, T.; Fujita, I.; Okuda, T.; Mizutani, T.; Kiyama, T.; Yoshiyuki, T.; Matsukura, N. Successful treatment of hepatic metastasis of gastric cancer with 5'-DFUR and Lentinan. Gan To Kagaku Ryoho., 1998, 25, 129-133.
20. Zhang, L.; Zhang, M.; Zhou, Q.; Chen, J.; Zeng, F. Solution properties of antitumor sulfated derivative of alpha-(1-->3)-Dglucan from Ganoderma lucidum. Biosci. Biotechnol. Biochem., 2000, 64, 2172-2178.
21. Sze, D.M.; Chan, G.C. Supplements for immune enhancement in hematologic malignancies. Hematology Am. Soc. Hematol. Educ. Program., 2009, 313-319.
22. Jang, K.J.; Son, I.S.; Shin, D.Y.; Yoon, H.M.; Choi, Y.H. Antiinvasive activity of ethanol extracts of Ganoderma lucidum through tightening of tight junctions and inhibition of matrix metalloproteinase activities in human gastric carcinoma cells. J. Acupunct. Meridian. Stud., 2011, 4, 225-235.
23. Kobayashi, H.; Yoshida, R.; Kanada, Y.; Fukuda, Y.; Yagyu, T.; Inagaki, K.; Kondo, T.; Kurita, N.; Suzuki, M.; Kanayama, N.; Terao, T. Suppressing effects of daily oral supplementation of betaglucan extracted from Agaricus blazei Murill on spontaneous and peritoneal disseminated metastasis in mouse model. J. Cancer Res. Clin. Oncol., 2005, 131, 527-538.
24. Oshiman, K.; Fujimiya, Y.; Ebina, T.; Suzuki, I.; Noji, M. Orally administered beta-1,6-D-polyglucose extracted from Agaricus blazei results in tumor regression in tumor-bearing mice. Planta. Med., 2002, 68, 610-614.
25. Niu, Y.C.; Liu, J.C.; Zhao, X.M.; Su, F.Q.; Cui, H.X. Immunostimulatory activities of a low molecular weight antitumoral polysaccharide isolated from Agaricus blazei Murill (LMPAB) in Sarcoma 180 ascitic tumor-bearing mice. Pharmazie., 2009, 64(7), 472-476.
26. Dong, Q.; Jia, L.M.; Fang, J.N. A beta-D-glucan isolated from the fruiting bodies of Hericium erinaceus and its aqueous conformation. Carbohydr. Res., 2006, 341, 791-795
27. Lee, J.S.; Min, K.M.; Cho, J.Y.; Hong, E.K. Study of macrophage activation and structural characteristics of purified polysaccharides from the fruiting body of Hericium erinaceus. J. Microbiol. Biotechnol., 2009, 19, 951-959.
28. Kim, S.P.; Kang, M.Y.; Kim, J.H.; Nam, S.H.; Friedman, M. Composition and mechanism of antitumor effects of Hericium erinaceus mushroom extracts in tumor-bearing mice. J. Agric. Food Chem., 2011, 59, 9861-9869.
29. Inomata, T.; Goodman, G.B.; Fryer, C.J.; Chaplin, D.J.; Palcic, B.; Lam, G.K.; Nishioka, A.; Ogawa, Y. Immune reaction induced by X-rays and pions and its stimulation by schizophyllan (SPG). Br. J. Cancer Suppl., 1996, 27, S122-125.
30. Kano, Y.; Kakuta, H.; Hashimoto, J. Inhibitory effect of metastasis by combined administration with interleukin-2 and sizofiran, a single glucan--immunohistochemical study. Biotherapy., 1996, 9, 263-269.
31. Arika, T.; Amemiya, K.; Nomoto, K. Combination therapy of radiation and Sizofiran (SPG) on the tumor growth and metastasis on squamous-cell carcinoma NR-S1 in syngeneic C3H/He mice. Biotherapy., 1992, 4, 165-170.
32. Sakurai, T.; Ohno, N.; Yadomae, T. Effects of fungal beta-glucan and interferon-gamma on the secretory functions of murine alveolar macrophages. J. Leukoc. Biol., 1996, 60, 118-124.
33. Minari, J.; Mochizuki, S.; Matsuzaki, T.; Adachi, Y.; Ohno, N.; Sakurai, K. Enhanced cytokine secretion from primary macrophages due to Dectin-1 mediated uptake of CpG DNA/β-1,3-glucan complex. Bioconjug. Chem., 2011, 22, 9-15.
34. Jones, D.; Gordon, A.H.; Bacon, J.S. Co-operative action by endoand exo-beta-(1 leads to 3)-glucanases from parasitic fungi in the degradation of cell-wall glucans of Sclerotinia sclerotiorum (Lib.) de Bary. Biochem. J., 1974, 140, 47-55.
35. Sakurai, T.; Ohno, N.; Suzuki, I.; Yadomae, T. Effect of soluble fungal (1,3)-beta-D-glucan obtained from Sclerotinia sclerotiorum on alveolar macrophage activation. Immunopharmacol., 1995, 30, 157-166.
36. Sakurai, T.; Suzuki, I.; Kinoshita, A.; Oikawa, S.; Masuda, A.; Ohsawa, M.; Yadomae, T. Effect of intraperitoneally administered beta-1,3-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the functions of murine alveolar macrophages. Chem. Pharm. Bull., 1991, 39, 214-217.
37. Misaki, A.; Kakuta, M.; Sasaki, T.; Tanaka, M.; Miyaji, H. Studies on interrelation of structure and antitumor effects of polysaccharides: antitumor action of periodate-modified, branched (1 goes to 3)-beta-D-glucan of Auricularia auricula-judae, and other polysaccharides containing (1 goes to 3)-glycosidic linkages. Carbohydr. Res., 1981, 92, 115-129.
38. Yoshikawa, N.; Kunitomo, M.; Kagota, S.; Shinozuka, K.; Nakamura, K. Inhibitory effect of cordycepin on hematogenic metastasis of B16-F1 mouse melanoma cells accelerated by adenosine-5'-diphosphate. Anticancer Res., 2009, 29, 3857-3860.
39. Fisher, M.; Yang, L.X. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy. Anticancer Res., 2002, 22, 1737-1754.
40. Xu, T.; Beelman, R.B.; Lambert, J.D. The Cancer Preventive Effects of Edible Mushrooms. Anticancer Agents Med. Chem., 2012.
41. Qi, C.; Cai, Y.; Gunn, L.; Ding, C.; Li, B.; Kloecker, G.; Qian, K.; Vasilakos, J.; Saijo, S.; Iwakura, Y.; Yannelli, J.R.; Yan, J. Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans. Blood., 2011, 117, 6825-6836.
42. Lee, J.N.; Lee, D.Y.; Ji, I.H.; Kim, G.E.; Kim, H.N.; Sohn, J.; Kim, S.; Kim, C.W. Purification of soluble beta-glucan with immuneenhancing activity from the cell wall of yeast. Biosci. Biotechnol. Biochem., 2001, 65, 837-841.
43. Cramer, D.E.; Wagner, S.; Li, B.; Liu, J.; Hansen, R.; Reca, R.; Wu, W.; Surma, E.Z.; Laber, D.A.; Ratajczak, M.Z.; Yan, J. Mobilization of hematopoietic progenitor cells by yeast-derived beta-glucan requires activation of matrix metalloproteinase-9. Stem Cells., 2008, 26, 1231-1240.
44. LeBlanc, B.W.; Albina, J.E.; Reichner, J.S. The effect of PGGbeta-glucan on neutrophil chemotaxis in vivo. J. Leukoc. Biol., 2006, 79, 667-675.
45. Li, B.; Cramer, D.; Wagner, S.; Hansen, R.; King, C.; Kakar, S.; Ding, C.; Yan, J. Yeast glucan particles activate murine resident macrophages to secrete proinflammatory cytokines via MyD88-and Syk kinase-dependent pathways. Clin. Immunol., 2007, 124, 170-181.
46. Liu, X.L.; Lin, N.; Zan, D.; Yuan, J.J.; Cai, D.L. Effect of zymosan on antioxidant and immune function of S180 tumor-bearing mice. Cell Biochem. Biophys., 2011, 60, 225-229.
47. Mariani, C.L.; Rajon, D.; Bova, F.J.; Streit, W.J. Nonspecific immunotherapy with intratumoral lipopolysaccharide and zymosan A but not GM-CSF leads to an effective anti-tumor response in subcutaneous RG-2 gliomas. J. Neurooncol., 2007, 85, 231-240.
48. Arika, T.; Amemiya, K.; Nomoto, K. Combination therapy of radiation and Sizofiran (SPG) on the tumor growth and metastasis on squamous-cell carcinoma NR-S1 in syngeneic C3H/He mice. Biotherapy., 1992, 4(2), 165-170.
49. Sveinbjørnsson, B.; Rushfeldt, C.; Seljelid, R.; Smedsrød, B. Inhibition of establishment and growth of mouse liver metastases after treatment with interferon gamma and beta-1,3-D-glucan. Hepatology, 1998, 27(5), 1241-1248.
50. Hamuro, J.; Takatsuki, F.; Suga, T.; Kikuchi, T.; Suzuki, M. Synergistic antimetastatic effects of lentinan and interleukin 2 with pre-and post-operative treatments. Jpn. J. Cancer Res., 1994, 85(12), 1288-1297.
51. Mizuno, T. Development of antitumor polysaccharides from mushroom fungi. Foods Food Ingred. J. Jpn., 1996, 167, 69-85.
52. Mushiake, H.; Tsunoda, T.; Nukatsuka, M.; Shimao, K.; Fukushima, M.; Tahara, H. Dendritic cells might be one of key factors for eliciting antitumor effect by chemoimmunotherapy in vivo. Cancer Immunol. Immunother., 2005, 54(2), 120-128.
53. Harnack, U.; Eckert, K.; Pecher, G. Beta-(1-3),(1-6)-D-glucan enhances the effect of low-dose cyclophosphamide treatment on A20 lymphoma in mice. Anticancer Res., 2011, 31(4), 1169-1172.
54. Kim, W.J.; Yoon, T.J.; Kim, D.W.; Moon, W.K.; Lee, K.H. Immunostimulating activity of beta-glucan isolated from the cell wall of mutant saccharomyces cerevisiae, and its anti-tumor application with cisplatin. Korean J. Food Nutr., 2010, 23(2), 141-146.
55. Mizuno, M.; Minato, K.; Ito, H.; Kawade, M.; Terai, H.; Tsuchida, H. Anti-tumor polysaccharide from the mycelium of liquid-cultured Agaricus blazei mill. Biochem. Mol. Biol. Int., 1999, 47, 707-714.
56. Okuyama, K.; Isono, K.; Juan, I.K.; Onoda, S.; Ochiai, T.; Yamamoto, Y.; Koide, Y.; Satoh, H. Evaluation of treatment for gastric cancer with liver metastasis. Cancer, 1985, 55(10), 2498-2505.
57. Shimizu, K.; Watanabe, S.; Watanabe, S.; Matsuda, K.; Suga, T.; Nakazawa, S.; Shiratori, K. Efficacy of oral administered superfine dispersed lentinan for advanced pancreatic cancer. Hepatogastroenterol., 2009, 56(89), 240-244.
58. Hazama, S.; Watanabe, S.; Ohashi, M.; Yagi, M.; Suzuki, M.; Matsuda, K.; Yamamoto, T.; Suga, Y.; Suga, T.; Nakazawa, S.; Oka, M. Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer. Anticancer Res., 2009, 29(7), 2611-2617.
59. Kataoka, H.; Shimura, T.; Mizoshita, T.; Kubota, E.; Mori, Y.; Mizushima, T.; Wada, T.; Ogasawara, N.; Tanida, S.; Sasaki, M.; Togawa, S.; Sano, H.; Hirata, Y.; Ikai, M.; Mochizuki, H.; Seno, K.; Itoh, S.; Kawai, T.; Joh, T. Lentinan with S-1 and paclitaxel for gastric cancer chemotherapy improve patient quality of life. Hepatogastroenterology, 2009, 56(90), 547-550.
60. Yoshino, S.; Tabata, T.; Hazama, S.; Iizuka, N.; Yamamoto, K.; Hirayama, M.; Tangoku, A.; Oka, M. Immunoregulatory effects of the antitumor polysaccharide lentinan on Th1/Th2 balance in patients with digestive cancers. Anticancer Res., 2000, 20(6C), 4707-4711.
61. Takeshita, K.; Watanuki, S.; Iida, M.; Saito, N.; Maruyama, M.; Sunagawa, M.; Habu, H.; Endo, M. Effect of lentinan on lymphocyte subsets of peripheral blood, lymph nodes, and tumor tissues in patients with gastric cancer. Surg. Today., 1993, 23(2), 125-129.
62. Demir, G.; Klein, H.O.; Mandel-Molinas, N.; Tuzuner, N. Beta glucan induces proliferation and activation of monocytes in peripheral blood of patients with advanced breast cancer. Int. Immunopharmacol., 2007, 7(1), 113-116.
63. Tari, K.; Satake, I.; Nakagomi, K.; Ozawa, K.; Oowada, F.; Higashi, Y.; Negishi, T.; Yamada, T.; Saito, H.; Yoshida, K. Effect of lentinan for advanced prostate carcinoma. Hinyokika Kiyo., 1994, 40(2), 119-123.
64. Yang, P.; Liang, M.; Zhang, Y.; Shen, B. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC. Adv. Ther., 2008, 25(8), 787-794.
65. Shimizu, Y.; Hasumi, K.; Masubuchi, K. Augmenting effect of sizofiran on the immunofunction of regional lymph nodes in cervical cancer. Cancer, 1992, 69(5), 1184-1194.
66. Knudsen, K.E.; Jensen, B.B.; Hansen, I. Digestion of polysaccharides and other major components in the small and large intestine of pigs fed on diets consisting of oat fractions rich in beta-D-glucan. Br. J. Nutr., 1993, 70(2), 537-556.
67. Ohno, N.; Terui, T.; Chiba, N.; Kurachi, K.; Adachi, Y.; Yadomae, T. Resistance of highly branched (1-->3)-beta-D-glucans to formolysis. Chem. Pharm. Bull., 1995, 43(6), 1057-1060.
68. Wang, H.; Weening, D.; Jonkers, E.; Boer, T.; Stellaard, F.; Small, A.C.; Preston, T.; Vonk, R.J.; Priebe, M.G. A curve fitting approach to estimate the extent of fermentation of indigestible carbohydrates. Eur. J. Clin. Invest., 2008, 38(11), 863-868.
69. Chan, G.C.; Chan, W.K.; Sze, D.M. The effects of beta-glucan on human immune and cancer cells. J. Hematol. Oncol., 2009, 2, 25.
70. Chen, J.; Seviour, R. Medicinal importance of fungal beta-(1-->3), (1-->6)-glucans. Mycol. Res., 2007, 111(pt6), 635-652.
71. Kurashige, S.; Akuzawa, Y.; Endo, F. Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine. Immunopharmacol. Immunotoxicol., 1997, 19(2), 175-183.
72. Brown, G.D.; Taylor, P.R.; Reid, D.M.; Willment, J.A.; Williams, D.L.; Martinez-Pomares, L.; Wong, S.Y.; Gordon, S. Dectin-1 is a major beta-glucan receptor on macrophages. J. Exp. Med., 2002, 196(3), 407-412.
73. Sato, M.; Sano, H.; Iwaki, D.; Kudo, K.; Konishi, M.; Takahashi, H.; Takahashi, T.; Imaizumi, H.; Asai, Y.; Kuroki, Y. Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are downregulated by lung collectin surfactant protein A. J. Immunol., 2003, 171(1), 417-425.
74. Young, R.E.; Thompson, R.D.; Larbi, K.Y.; La, M.; Roberts, C.E.; Shapiro, S.D.; Perretti, M.; Nourshargh, S. Neutrophil elastase (NE)-deficient mice demonstrate a nonredundant role for NE in neutrophil migration, generation of proinflammatory mediators, and phagocytosis in response to zymosan particles in vivo. J. Immunol., 2004, 172(7), 4493-4502.
75. Kim, H.S.; Hong, J.T.; Kim, Y.; Han, S.B. Stimulatory Effect of β-glucans on Immune Cells. Immune. Netw., 2011, 11(4), 191-195.
76. Li, B.; Cai, Y.; Qi, C.; Hansen, R.; Ding, C.; Mitchell, T.C.; Yan, J. Orally administered particulate beta-glucan modulates tumorcapturing dendritic cells and improves antitumor T-cell responses in cancer. Clin. Cancer Res., 2010, 16(21), 5153-5164.
77. Moradali, M.F.; Mostafavi, H.; Ghods, S.; Hedjaroude, G.A. Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). Int. Immunopharmacol., 2007, 7(6), 701-724.
78. Chihara, G.; Hamuro, J.; Maeda, Y.Y.; Shiio, T.; Suga, T.; Takasuka, N.; Sasaki, T. Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview. Cancer Detect. Prev. Suppl., 1987, 1, 423-443.
79. Nakano, H.; Namatame, K.; Nemoto, H.; Motohashi, H.; Nishiyama, K.; Kumada, K. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group. Hepatogastroenterol., 1999, 46(28), 2662-2668.
80. Aoki, T. Lentinan. In: Fenichel RL, Chirgis MA (eds) Immune modulation agents and their mechanisms. Immunol. Stud., 1984, 25, 62-77.
81. Mizuno, T.; Yeohlui, P.; Kinoshita, T.; Zhuang, C.; Ito, H.; Mayuzumi, Y. Antitumor activity and chemical modification of polysaccharides from Niohshimeji mushroom, Tricholoma giganteum. Biosci. Biotechnol. Biochem., 1996, 60, 30-33.
82. Hobbs, C. Medicinal mushrooms: an exploration of tradition, healing and culture. Botanica Press, Santa Cruz, Calif. 1995
83. Ohno, N.; Jinushi, T.; Yadomae, T. Th1-Oriented Immunomodulating Activity of Gel-Forming Fungal (1→3)-Beta-Glucans. Int. J. Med. Mushroom, 2002, 2, 19-35.
84. Hong, F.; Yan, J.; Baran, J.T.; Allendorf, D.J.; Hansen, R.D.; Ostroff, G.R.; Xing, P.X.; Cheung, N.K.; Ross, G.D. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J. Immunol., 2004, 173(2), 797-806.
85. Rice, P.J.; Adams, E.L.; Ozment-Skelton, T.; Gonzalez, A.J.; Goldman, M.P.; Lockhart, B.E.; Barker, L.A.; Breuel, K.F.; Deponti, W.K.; Kalbfleisch, J.H.; Ensley, H.E.; Brown, G.D.; Gordon, S.; Williams, D.L. Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge. J. Pharmacol. Exp. Ther., 2005, 314(3), 1079-1086.
86. Ooi, V.E.C.; Liu, F. A review of pharmacological activities of mushroom polysaccharides. Int. J. Med. Mushrooms., 1999, 1, 195-206.
87. Ross, G.D.; Cain, J.A.; Myones, B.L.; Newman, S.L.; Lachmann, P.J. Specificity of membrane complement receptor type three (CR3) for beta-glucans. Complement., 1987, 4(2), 61-74.
88. Thornton, B.P.; Větvicka, V.; Pitman, M.; Goldman, R.C.; Ross, G.D. Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol., 1996, 156(3), 1235-1246.
89. Zimmerman, J.W.; Lindermuth, J.; Fish, P.A.; Palace, G.P.; Stevenson, T.T.; DeMong, D.E. A novel carbohydrateglycosphingolipid interaction between a beta-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes. J. Biol. Chem., 1998, 273(34), 22014-22020.
90. Rice, P.J.; Kelley, J.L.; Kogan, G.; Ensley, H.E.; Kalbfleisch, J.H.; William Browder, I.; Williams, D.L. Human monocyte scavenger receptors are pattern recognition receptors for (1→3)-β-D-glucans. J. Leukoc. Biol., 2002, 72(1), 140-146.
91. Shao, B.M.; Dai, H.; Xu, W.; Lin, Z.B.; Gao, X.M. Immune receptors for polysaccharides from Ganoderma lucidum. Biochem. Biophys. Res. Commun., 2004, 323(1), 133-141.
92. Ross, G.D. Regulation of the adhesion versus cytotoxic functions of the Mac-1/CR3/α(m)β2-integrin glycoprotein. Crit. Rev. Immunol., 2000, 20, 197-222.
93. Herre, J.; Gordon, S.; Brown, G.D. Dectin-1 and its role in the recognition of β-glucans by macrophages. Mol. Immunol., 2004, 40, 869-876.
94. Underhill, D.M.; Rossnagle, E.; Lowell, C.A.; Simmons, R.M. Dectin-1 activates Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen production. Blood., 2005, 106, 2543-2550.
95. Brown, G.D.; Gordon, S. Immune recognition. A new receptor for beta-glucans. Nature, 2001, 413, 36-37.
96. Steele, C.; Marrero, L.; Swain, S.; Harmsen, A.G.; Zheng, M.; Brown, G.D.; Gordon, S.; Shellito, J.E.; Kolls, J.K. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the dectin-1 β-glucan receptor. J. Exp. Med., 2003, 198, 1677-1688.
97. Willment, J.A.; Marshall, A.S.; Reid, D.M.; Williams, D.L.; Wong, S.Y.C.; Gordon, S.; Brown, G.D. The human β-glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells. Eur. J. Immunol., 2005, 35, 1539-1547.
98. Taylor, P.R.; Tsoni, S.V.; Willment, J.A.; Dennehy, K.M.; Rosas, M.; Findon, H.; Haynes, K.; Steele, C.; Botto, M.; Gordon, S.; Brown, G.D. Dectin-1 is required for β-glucan recognition and control of fungal infection. Nat. Immunol., 2007, 8, 31-38.
99. Taylor, P.R.; Brown, G.D.; Herre, J.; Williams, D.L.; Willment, J.A.; Gordon, S. The role of SIGNR1 and the beta-glucan receptor (dectin-1) in the nonopsonic recognition of yeast by specific macrophages. J. Immunol., 2004, 172(2), 1157-1162.
100. Brown, G.D. Dectin-1: A signalling non-TLR pattern-recognition receptor. Nat. Rev. Immunol., 2006, 6(1), 33-43.
101. Underhill, D.M.; Ozinsky, A.; Hajjar, A.M.; Stevens, A.; Wilson, C.B.; Bassetti, M.; Aderem, A. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature, 1999, 401(6755), 811-815.
102. Brown, G.D.; Herre, J.; Williams, D.L.; Willment, J.A.; Marshall, A.S.; Gordon, S. Dectin-1 mediates the biological effects of betaglucans. J. Exp. Med., 2003, 197(9), 1119-1124.
103. Gantner, B.N.; Simmons, R.M.; Canavera, S.J.; Akira, S.; Underhill, D.M. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med., 2003, 197(9), 1107-1117.
104. Rogers, N.C.; Slack, E.C.; Edwards, A.D.; Nolte, M.A.; Schulz, O.; Schweighoffer, E.; Williams, D.L.; Gordon, S.; Tybulewicz, V.L.; Brown, G.D.; Reis e Sousa, C. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity, 2005, 22(4), 507-517.
105. Yadav, M.; Schorey, J.S. The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood, 2006, 108(9), 3168-3175.
106. Yoshitomi, H.; Sakaguchi, N.; Kobayashi, K.; Brown, G.D.; Tagami, T.; Sakihama, T.; Hirota, K.; Tanaka, S.; Nomura, T.; Miki, I.; Gordon, S.; Akira, S.; Nakamura, T.; Sakaguchi, S. A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J. Exp. Med., 2005, 201(6), 949-960.
107. Herre, J.; Marshall, A.S.; Caron, E.; Edwards, A.D.; Williams, D.L.; Schweighoffer, E.; Tybulewicz, V.; Reis e Sousa, C.; Gordon, S.; Brown, G.D. Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. Blood, 2004, 104(13), 4038-4045.
108. Vetyicka, V. Glucan-immunostimulant, adjuvant, potential drug. World J. Clin. Oncol., 2011, 2(2), 115-119.
109. Li, B.; Allendorf, D.J.; Hansen, R.; Marroquin, J.; Ding, C.; Cramer, D.E.; Yan, J. Yeast β-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Sykphosphatidylinositol 3-Kinase pathway. J. Immunol., 2006, 177, 1661-1669.
110. Józefowski, S.; Yang, Z.; Marcinkiewicz, J.; Kobzik, L. Scavenger receptors and β-glucan receptors participate in the recognition of yeasts by murine macrophages. Inflamm. Res., 2012, 61(2), 113-126.
111. Nakayama, H.; Yoshizaki, F.; Prinetti, A.; Sonnino, S.; Mauri, L.; Takamori, K.; Ogawa, H.; Iwabuchi, K. Lyn-coupled LacCerenriched lipid rafts are required for CD11b/CD18-mediated neutrophil phagocytosis of nonopsonized microorganisms. J. Leukoc. Biol., 2008, 83(3), 728-741.
112. Soong, G.; Reddy, B.; Sokol, S.; Adamo, R.; Prince, A. TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. J. Clin. Invest., 2004, 113(10), 1482-1489.
113. Nakahira, K.; Kim, H.P.; Geng, X.H.; Nakao, A.; Wang, X.; Murase, N.; Drain, P.F.; Wang, X.; Sasidhar, M.; Nabel, E.G.; Takahashi, T.; Lukacs, N.W.; Ryter, S.W.; Morita, K.; Choi, A.M. Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J. Exp. Med., 2006, 203(10), 2377-2389.
114. Triantafilou, M.; Gamper, F.G.; Haston, R.M.; Mouratis, M.A.; Morath, S.; Hartung, T.; Triantafilou, K. Membrane sorting of tolllike receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J. Biol. Chem., 2006, 281(41), 31002-31011.
115. Xu, S.; Huo, J.; Gunawan, M.; Su, I.H.; Lam, K.P. Activated dectin-1 localizes to lipid raft microdomains for signaling and activation of phagocytosis and cytokine production in dendritic cells. J. Biol. Chem., 2009, 284(33), 22005-22011.
116. Czop, J.K. The role of beta-glucan receptors on blood and tissue leukocytes in phagocytosis and metabolic activation. Pathol. Immunopathol. Res., 1986, 5(3-5), 286-296.
117. Williams, D.; Mueller, A.; Erowder, W. Glucan-based macrophage stimulators a review of their anti-infective potential. Clinical Immunotherapy, 1996, 5, 392-399.
118. Falch, B.H.; Espevik, T.; Ryan, L.; Stokke, B.T. The cytokine stimulating activity of (1→3)-β-D-glucans is dependent on the triple helix conformation. Carbohydr. Res., 2000, 329, 587-596.
119. Zhang, L.; Li, X.; Xu, X.; Zeng, F. Correlation between antitumor activity, molecular weight, and conformation of lentinan. Carbohydr. Res., 2005, 340, 1515-1521.
120. Mueller, A.; Raptis, J.; Rice, P.J.; Kalbfleisch, J.H.; Stout, R.D.; Ensley, H.E.; Browder, W.; Williams, D.L. The influence of glucan polymer structure and solution conformation on binding to (1-->3)-beta-D-glucan receptors in a human monocyte-like cell line. Glycobiol., 2000, 10(4), 339-346.
121. Wang, Y.; Zhang, L.; Li, Y.; Hou, X.; Zeng, F. Correlation of structure to antitumor activities of five derivatives of a beta-glucan from Poria cocos sclerotium. Carbohydr. Res., 2004, 339(15), 2567-2574.
122. Di Luzio, N.R.; Williams, D.L.; McNamee, R.B.; Edwards, B.F.; Kitahama, A. Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. Int. J. Cancer., 1979, 24(6), 773-779.
123. Di Luzio, N.R.; Williams, D.L.; McNamee, R.B.; Malshet, V.G. Comparative evaluation of the tumor inhibitory and antibacterial activity of solubilized and particulate glucan. Rec. Results Cancer Res., 1980, 75, 165-172.
124. Xiao, Z.; Trincado, C.A.; Murtaugh, M.P. Beta-glucan enhancement of T cell IFNgamma response in swine. Vet. Immunol. Immunopathol., 2004, 102(3), 315-320.
125. Brown, G.D.; Gordon, S. Fungal β-Glucans and Mammalian Immunity. Immunity., 2003, 19, 311-315.
126. O'Brien, X.M.; Heflin, K.E.; Lavigne, L.M.; Yu, K.; Kim, M.; Salomon, A.R.; Reichner, J.S. Lectin site ligation of CR3 induces conformational changes and signaling. J. Biol. Chem., 2012, 287(5), 3337-3348.
127. Xiao, G.; Miyazato, A.; Abe, Y.; Zhang, T.; Nakamura, K.; Inden, K.; Tanaka, M.; Tanno, D.; Miyasaka, T.; Ishii, K.; Takeda, K.; Akira, S.; Saijo, S.; Iwakura, Y.; Adachi, Y.; Ohno, N.; Yamamoto, N.; Kunishima, H.; Hirakata, Y.; Kaku, M.; Kawakami, K. Activation of myeloid dendritic cells by deoxynucleic acids from Cordyceps sinensis via a Toll-like receptor 9-dependent pathway. Cell Immunol., 2010, 263, 241-250
128. Pao, H.Y.; Pan, B.S.; Leu, S.F.; Huang, B.M. Cordycepin stimulated steroidogenesis in MA-10 mouse leydig tumor cells through the protein kinase C Pathway. J. Agric. Food Chem., 2012, 60, 4905-4913.
129. Xia, Y.; Vetvicka, V.; Yan, J.; Hanikýrová, M.; Mayadas, T.; Ross, G.D. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3bopsonized target cells. J. Immunol., 1999, 162(4), 2281-2290.
130. Wang, J.; Gigliotti, F.; Maggirwar, S.; Johnston, C.; Finkelstein, J.N.; Wright, T.W. Pneumocystis carinii activates the NF-kappaB signaling pathway in alveolar epithelial cells. Infect. Immun., 2005, 73(5), 2766-2777.